24 January 2020
Visiongain’s new report the Pharmaceutical Glass Packaging Market Report 2020-2030: Forecasts by Product (Vials, Bottles, Cartridges & Syringes, Ampoules) plus analysis of leading companies indicates that the global Pharmaceutical Glass Packaging market will grow at a CAGR over 6% by 2030.
It is anticipated that high demand from the pharmaceutical industry and widespread use of generic injectable drugs would drive growth. Glass prohibits the entry into the primary tank of atmospheric gases such as oxygen and carbon dioxide, thereby eliminating pharmaceutical pollution. It also avoids potential degradation of the drug, such as oxidation and hydrolysis. Therefore, glass packaging improves the durability of the drug by preventing volatile ingredient escape. All of these factors are expected to increase the demand for the product in the near future. The new and improved products are made using glass chemistry and ion-exchange processes which resulted in the reduction of the surface friction coefficient and the inherent production of strong and damage-resistant glass. During the forecast period, this trend is expected to drive demand for pharmaceutical glass packaging products. Due to the high inertia of these products for most chemicals, the demand for glass vials is expected to remain high over the forecast period. In fact, the vials prohibit entry into the tank of atmospheric gases such as oxygen and carbon dioxide.
The vials, including oxidation and hydrolysis, also stop possible degradation. The vials stop the substance from escape into the environment through unstable ingredients and thus keep the drug / product safe. By addition, both glass and plastic are recyclable. The latter has its own set of drawbacks, though, as it can only be recycled back into glass. As a result, plastic loses its quality, as various items such as plastic lumber, carpet filling, and foam packaging among others can be reused, thereby restricting the growth of the industry.
Due to the large number of regional and global players, the market for pharmaceutical glass packaging is highly fragmented. The top ten players from the industry combined, however, accounted for most of the revenue in 2018. Because of the presence of a well-established pharmaceutical industry in these countries, a large number of manufacturers are mainly concentrated in developed regions, such as North America and Europe.
Growing importance of biotech drugs and cost-sensitivity in the healthcare sector has resulted in the establishment of stringent drug delivery products regulations. Most manufacturers of glass pharmaceutical packaging invest in products that aim to increase the drug's shelf-life, which is expected to increase demand in the coming years. Over the past couple of years, the global market for generic drugs has seen an increase due to the increase in pharmaceutical patent expiration, the aging population, and the increase in the prevalence of chronic diseases. Because of its superior barrier properties and regulatory ease, generics growth is expected to fuel demand for glass packaging.
The U.S. market is expected to remain a key area for various pharmaceutical glass packaging business activities. This is due to the significant rise in the country's amount of generics that is expected to undergo a rapid change in market dynamics mainly due to increased competitive intensity and consolidation of customers. Both combined instances put pressure on demand that is supposed to restrict branded product sales through patent expiries and low-cost generics.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth